Only a write down of 37.5c per share. NTA backing still $1.725 per share. Very moderate writedown IMO. Like last year could have been alot worse. If it was $400mil i might be worried.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor